AstraZeneca PLC
1566.00
31-January-25 11:29:40
15 minutes delayed
Stocks
+10.00
+0.64%
Today's range
1557.50 - 1572.00
ISIN
N/A
Source
NASD.OMX SE
-
AstraZeneca's Tagrisso With Chemotherapy Approved In US To Treat Lung Cancer
19 Feb 2024 04:46:28 By NASDAQ US Markets
-
AstraZeneca Enters Oversold Territory
12 Feb 2024 13:12:53 By NASDAQ Stocks
-
NetDania - New 12 months Low: AstraZeneca PLC
12 Feb 2024 03:15:03 By NetDania Notify
-
AstraZeneca Plc (AZN) Q4 2023 Earnings Call Transcript
08 Feb 2024 16:26:03 By NASDAQ US Markets
-
Ionis Says Eplontersen Got Fast Track Status To Treat Transthyretin-mediated Amyloid Cardiomyopathy
08 Feb 2024 08:43:49 By NASDAQ US Markets
-
NetDania - New 12 months Low: AstraZeneca PLC
08 Feb 2024 06:35:34 By NetDania Notify
-
AstraZeneca Q4 Profit Rises; Revenue Ex COVID-19 Up 16% At CER
08 Feb 2024 02:49:12 By NASDAQ US Markets
-
AstraZeneca's (AZN) sBLA for Enhertu Gets FDA's Priority Tag
30 Jan 2024 09:02:12 By NASDAQ Stocks
-
AstraZeneca: FDA Grants ENHERTU Priority Review For Metastatic HER2-Positive Solid Tumors
29 Jan 2024 08:32:09 By NASDAQ US Markets
-
AZN March 8th Options Begin Trading
25 Jan 2024 11:49:47 By NASDAQ Stocks
-
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
22 Jan 2024 07:32:47 By NASDAQ US Markets
-
Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial
08 Jan 2024 08:09:47 By NASDAQ US Markets
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 11:38:29 By NASDAQ Stocks
-
Bullish Two Hundred Day Moving Average Cross - AZN
04 Jan 2024 11:34:42 By NASDAQ US Markets
-
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
02 Jan 2024 09:45:15 By NASDAQ US Markets
-
AstraZeneca To Buy Gracell For Up To $1.2 Bln
26 Dec 2023 03:23:07 By NASDAQ US Markets
-
AZN :FDA Oks Wainua For Treatment Of Polyneuropathy Of Hereditary Transthyretin-Mediated Amyloidosis
21 Dec 2023 20:47:36 By NASDAQ US Markets
-
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
21 Dec 2023 20:44:53 By MarketWatch
-
AstraZeneca Will Acquire RSV Vaccine Developer Icosavax For $1.1 Billion
12 Dec 2023 04:30:35 By Forbes - World
-
AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal
12 Dec 2023 03:42:28 By NASDAQ US Markets